Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar Involvement
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- ABBVIE INC.
AbbVie
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
55 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Beacon Dermatology Inc /id# 220940
Calgary, Alberta, Canada
- Dr. Chih-Ho Hong Medical Inc. /id# 220941
Surrey, British Columbia, Canada
- Dr. Irina Turchin Pc Inc. /id# 220938
Fredericton, New Brunswick, Canada
- Newlab Clinical Research Inc. /id# 220934
St. John's, Newfoundland and Labrador, Canada
- Dr. S.K. Siddha Medicine Professional Corporation /id# 220936
Newmarket, Ontario, Canada
- Research Toronto /id# 220939
Toronto, Ontario, Canada
- Innovaderm Research Inc. /id# 222126
Montreal, Quebec, Canada
- Centre de Recherche Dermatologique Du Quebec Metropolitain /id# 220935
Québec, Quebec, Canada
- Dr. Samuel Sanchez Psc /id# 218789
Caguas, Puerto Rico
- Alma M. Cruz Santana, Md-Private Practice /id# 218790
Carolina, Puerto Rico
- Pan American Center for Oncology Trials, Llc /id# 218788
Rio Piedras, Puerto Rico
- Clinical Research Puerto Rico /id# 218787
San Juan, Puerto Rico
- Gcm Medical Group, Psc /id# 218786
San Juan, Puerto Rico
- Hospital Universitario Basurto /id# 220904
Bilbao, Vizcaya, Spain
- Hospital Universitario Ramon Y Cajal /id# 220908
Madrid, Spain
- Hospital Universitario de la Princesa /id# 224911
Madrid, Spain
- Hospital Regional Universitario de Malaga /id# 220900
Málaga, Spain
- Hospital Universitario Virgen del Rocio /id# 220907
Seville, Spain
- Hospital General Universitario de Valencia /id# 220898
Valencia, Spain
- Hospital Universitario Y Politecnico la Fe /id# 220903
Valencia, Spain
- Hospital Clinico Universitario Lozano Blesa /id# 222492
Zaragoza, Spain
- Advanced Research Associates - Glendale /id# 219197
Glendale, Arizona, United States
- Burke Pharmaceutical Research /id# 223349
Hot Springs, Arkansas, United States
- Nw Arkansas Clinical Trials Center /id# 231602
Rogers, Arkansas, United States
- Dermatology Research Associates /id# 219195
Los Angeles, California, United States
- Integrative Skin Science and Research /id# 219216
Sacramento, California, United States
- Medderm Associates /id# 219210
San Diego, California, United States
- Colorado Center for Dermatology, Pllc /id# 219223
Centennial, Colorado, United States
- Skin Care Research - Hollywood /id# 219184
Hollywood, Florida, United States
- Gsi Clinical Research, Llc /id# 219175
Margate, Florida, United States
- Savin Medical Group, Llc /id# 227754
Miami Lakes, Florida, United States
- Lenus Research & Medical Group /id# 219202
Sweetwater, Florida, United States
- Hamilton Research, Llc /id# 219224
Alpharetta, Georgia, United States
- Arlington Dermatology /id# 219211
Rolling Meadows, Illinois, United States
- Northshore University Health System Dermatology Clinical Trials Unit /id# 219220
Skokie, Illinois, United States
- Dawes Fretzin, Llc /id# 219219
Indianapolis, Indiana, United States
- the Dermatology Center Psc - New Albany /id# 219183
New Albany, Indiana, United States
- Epiphany Dermatology of Kansas Llc /id# 219208
Overland Park, Kansas, United States
- Allcutis Research Llc /id# 222272
Methuen, Massachusetts, United States
- David Fivenson, Md, Plc /id# 219180
Ann Arbor, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Feb 2021
- Primary completion
- 20 Apr 2023
- Completion
- 20 Apr 2023
- Last update posted
- 14 Jun 2024
- Registered enrollment
- 174
- Registry id
- NCT04713592
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.